Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data.

Renon, Francesca; Rago, Anna; Liccardo, Biagio; D'Andrea, Antonello; Riegler, Lucia; Golino, Paolo; Nigro, Gerardo; Russo, Vincenzo

Renon, Francesca; Rago, Anna; Liccardo, Biagio; D'Andrea, Antonello; Riegler, Lucia; Golino, Paolo; Nigro, Gerardo; Russo, Vincenzo.

Afiliação

Renon F; Division of Cardiology, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli" Monaldi Hospital, Naples, Italy.
Rago A; Department of Cardiology, Monaldi Hospital, Naples, Italy.
Liccardo B; Department of Cardiology, Monaldi Hospital, Naples, Italy.
D'Andrea A; Unit of Cardiology and Intensive Coronary Care, Umberto I Hospital, Nocera Inferiore, Italy.
Riegler L; Unit of Cardiology and Intensive Coronary Care, Umberto I Hospital, Nocera Inferiore, Italy.
Golino P; Division of Cardiology, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli" Monaldi Hospital, Naples, Italy.
Nigro G; Division of Cardiology, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli" Monaldi Hospital, Naples, Italy.
Russo V; Division of Cardiology, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli" Monaldi Hospital, Naples, Italy.

Semin Thromb Hemost ; 47(2): 150-160, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33636746

Assuntos

Anticoagulantes/uso terapêutico; Plasma/efeitos dos fármacos; Administração Oral; Anticoagulantes/farmacologia; Humanos; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasma / Anticoagulantes Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google